Koninklijke Philips NV ADR (NYSE:PHG)
20.37 USD
-0.240 1.165%Previous Close (in USD) | 20.61 |
---|---|
Change | -0.240 1.165% |
52 W H/L (in USD) | 23.490/14.630 |
EBITDA (in USD) | 1000.25M |
PE Ratio | -- |
Volume | 1032830 |
Diluted Eps TTM | -0.64 |
Total Assets (in USD) | 30688M |
---|---|
Total Liabilities (in USD) | 17405M |
Revenue TTM (in USD) | 18528.999M |
Cash (in USD) | 1172M |
Market Cap (in USD) | 21,038.275 M |
Revenue Per Share TTM | 20.995 |
Gross Profit TTM (in USD) | 7194M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Koninklijke Philips NV ADR
Employees: 70741
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Dr. Paulus A. Stoffels M.D., Ph.D. | Independent Vice Chairman of Supervisory Board & Sec. | 1962 |
2. | Mr. Abhijit Bhattacharya | Exec. VP, CFO & Member of the Board of Management | 1961 |
3. | Mr. Marnix J. van Ginneken | Exec. VP, Chief Legal Officer & Member of the Board of Management | 1973 |
4. | Mr. François Adrianus van Houten | Advisor | 1960 |
5. | Mr. Roy Jakobs | CEO & Pres | 1974 |
6. | Mr. Willem Appelo | Chief Operations Officer | 1965 |
7. | Mr. Leandro Mazzoni | Head of Investor Relations | NA |
8. | Ms. Daniela Seabrook | Exec. VP & Chief HR Officer | 1973 |
9. | Mr. Sean Carney | Chief Design Officer | NA |
10. | Mr. Jeroen Tas | Exec. Officer | 1959 |
Peers
Sector: Healthcare
Industry: Medical Devices
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ABT
Abbott Laboratories |
+0.010 0.009% | 111.95 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
SYK
Stryker Corporation |
+0.320 0.091% | 353.96 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
MDT
Medtronic PLC |
+0.060 0.072% | 83.57 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
BSX
Boston Scientific Corp |
+0.120 0.178% | 67.43 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Income Before Tax | -1731M | 509M | 1490M | 1529M | 1503M |
Minority Interest | -3M | -4M | 31M | 28M | 29M |
Net Income | -1618M | 612M | 1187M | 1168M | 1090M |
Selling General Administrative | 671M | 599M | 668M | 631M | 631M |
Gross Profit | 7194M | 7168M | 8781M | 8875M | 8553M |
Reconciled Depreciation | 1602M | 1323M | 1520M | 1402M | 1089M |
Ebit | -116M | 553M | 1542M | 1644M | 1767M |
Ebitda | 1486M | 2020M | 3214M | 3164M | 2856M |
Depreciation And Amortization | 1602M | 1467M | 1672M | 1520M | 1089M |
Operating Income | -116M | 553M | 1542M | 1644M | 1719M |
Other Operating Expenses | 17998M | 16603M | 17993M | 17837M | 16403M |
Interest Expense | 258M | 188M | 204M | 233M | 264M |
Tax Provision | -113M | -103M | 284M | 337M | 193M |
Interest Income | 58M | 149M | 160M | 69M | 154M |
Net Interest Income | -200M | -39M | -44M | -164M | -204M |
Income Tax Expense | -113M | -103M | 284M | 337M | 193M |
Total Revenue | 17827M | 17156M | 19535M | 19482M | 18121M |
Total Operating Expenses | 7365M | 6615M | 7239M | 7230M | 6835M |
Cost Of Revenue | 10633M | 9988M | 10754M | 10607M | 9568M |
Total Other Income Expense Net | -1615M | -44M | -52M | -115M | -2M |
Net Income From Continuing Ops | -1618M | 612M | 1205M | 1192M | 1310M |
Net Income Applicable To Common Shares | -1608M | 3319M | 1187M | 1167M | 1090M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Total Assets | 30688M | 30961M | 27713M | 26983M | 26019M |
Intangible Assets | 3526M | 3650M | 2997M | 3466M | 3589M |
Other Current Assets | 490M | 493M | 424M | 477M | 469M |
Total Liab | 17405M | 16487M | 15812M | 14358M | 13902M |
Total Stockholder Equity | 13249M | 14438M | 11870M | 12597M | 12088M |
Other Current Liab | 3339M | 3581M | 3149M | 3178M | 3368M |
Common Stock | 178M | 177M | 182M | 179M | 185M |
Capital Stock | 178M | 177M | 182M | 179M | 185M |
Retained Earnings | 6832M | 9344M | 7827M | 8296M | 8266M |
Good Will | 10238M | 10637M | 8014M | 8654M | 8503M |
Other Assets | 2551M | 1M | 2744M | 2682M | 2862M |
Cash | 1172M | 2303M | 3226M | 1425M | 1688M |
Cash And Equivalents | 1172M | 2303M | 3226M | 1425M | 1688M |
Total Current Liabilities | 7934M | 7450M | 7736M | 6945M | 7943M |
Current Deferred Revenue | 1696M | 1491M | 1239M | 1170M | 878M |
Net Debt | 7029M | 4676M | 3708M | 4022M | 3133M |
Short Term Debt | 931M | 506M | 1229M | 508M | 1394M |
Short Long Term Debt | 931M | 506M | 1229M | 110M | 1306M |
Short Long Term Debt Total | 8201M | 6979M | 6934M | 5447M | 4821M |
Other Stockholder Equity | 4751M | 13513M | 12028M | 11766M | 26428M |
Property Plant Equipment | 2638M | 2699M | 2682M | 2866M | 1509M |
Total Current Assets | 10259M | 10347M | 11227M | 9439M | 9572M |
Long Term Investments | 1197M | 1056M | 670M | 481M | 558M |
Short Term Investments | 11M | 2M | 0M | 1M | 436M |
Net Receivables | 4337M | 3967M | 4306M | 4712M | 4182M |
Long Term Debt | 7270M | 6473M | 5705M | 3768M | 3003M |
Inventory | 4049M | 3450M | 2993M | 2773M | 2674M |
Accounts Payable | 1968M | 1872M | 2119M | 2089M | 2303M |
Accumulated Other Comprehensive Income | 1488M | 748M | -340M | 652M | 11903M |
Non Currrent Assets Other | 381M | 355M | 303M | 226M | 211M |
Non Current Assets Total | 20429M | 20613M | 16486M | 17544M | 16447M |
Capital Lease Obligations | 1082M | 1220M | 1215M | 1381M | 236M |
Long Term Debt Total | 7018M | 6473M | 5705M | 4877M | 3239M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -1487M | -3672M | -1316M | -603M | -1486M |
Total Cashflows From Investing Activities | -1487M | -3672M | -1316M | -603M | -1486M |
Total Cash From Financing Activities | 500M | -2347M | 483M | -1665M | -1192M |
Net Income | -1618M | 612M | 1205M | 1192M | 1310M |
Change In Cash | -1131M | -923M | 1801M | -263M | -251M |
Begin Period Cash Flow | 2303M | 3226M | 1425M | 1688M | 1939M |
End Period Cash Flow | 1172M | 2303M | 3226M | 1425M | 1688M |
Total Cash From Operating Activities | -173M | 1629M | 2777M | 2031M | 1780M |
Depreciation | 1602M | 1323M | 1520M | 1402M | 1089M |
Other Cashflows From Investing Activities | -681M | 49M | -13M | 385M | -174M |
Dividends Paid | 412M | 482M | 1M | 453M | 401M |
Change To Inventory | -572M | -581M | -584M | -175M | -394M |
Sale Purchase Of Stock | -187M | -1636M | -343M | -1376M | -1042M |
Other Cashflows From Financing Activities | 2559M | 50M | 1079M | 867M | 1318M |
Capital Expenditures | 806M | 763M | 942M | 1013M | 843M |
Change In Working Capital | -1144M | 13M | -133M | -669M | -500M |
Other Non Cash Items | 1005M | -324M | -214M | -329M | 173M |
Free Cash Flow | -979M | 866M | 1835M | 1018M | 937M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | FMI Large Cap Investor | 5 months ago | 2090000 |
2. | DFA International Core Equity I | 4 months ago | 1238372 |
3. | Transamerica Mid Cap Value Opps I3 | 3 months ago | 1056766 |
4. | Fidelity® Growth & Income | 4 months ago | 1025702 |
5. | Fidelity® Series Large Cap Stock | 4 months ago | 772502 |
6. | Russell Inv Tax-Managed US Large Cap S | 3 months ago | 744177 |
7. | SKBA Capital Value Plus | 5 months ago | 542701 |
8. | MDPIM US Equity Pool | 5 months ago | 529373 |
9. | SEB LI BlackRock US Basic Value USD | 6 months ago | 484962 |
10. | Strategic Advisers® Fidelity US TtlStk | 4 months ago | 423496 |
11. | Fiduciary Mgt of Milwaukee Lg-Cap Eq | 5 months ago | 417104 |
12. | 1832 AM U.S. Low Volatility Equity LP I | 4 months ago | 408575 |
13. | Liberty All-Star Equity | 5 months ago | 405046 |
14. | Dimensional International Value ETF | 3 months ago | 319498 |
15. | UBS Global Equity Healthcare | 5 months ago | 264774 |
16. | BlackRock Mid Cap Value | 3 months ago | 256402 |
17. | Causeway Simulated Global Val ADR Model | 5 months ago | 245490 |
18. | VIP Growth & Income Initial | 4 months ago | 245419 |
19. | Transamerica Small/Mid Cap Value A | 3 months ago | 241011 |
20. | Dimensional International Core Eq 2 ETF | 3 months ago | 237183 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | EXOR NV | 5 months ago | 139297503 |
2. | FMR Inc | 5 months ago | 9516906 |
3. | Fiduciary Management, Inc. of Milwaukee | 5 months ago | 7716170 |
4. | BlackRock Inc | 5 months ago | 6540213 |
5. | Mondrian Investment Partners Ltd | 5 months ago | 3075529 |
6. | Macquarie Group Ltd | 5 months ago | 2741488 |
7. | Dimensional Fund Advisors, Inc. | 5 months ago | 2679177 |
8. | Morgan Stanley - Brokerage Accounts | 5 months ago | 2658630 |
9. | Thompson, Siegel & Walmsley LLC | 5 months ago | 2563805 |
10. | Perpetual Ltd | 5 months ago | 2041922 |
11. | Brandywine Global Investment Mgmt LLC | 5 months ago | 1832673 |
12. | Bank of America Corp | 5 months ago | 1681055 |
13. | Becker Capital | 5 months ago | 1425923 |
14. | Northern Trust Corp | 5 months ago | 1213117 |
15. | Millennium Management LLC | 5 months ago | 1122522 |
16. | Causeway Capital Management LLC | 5 months ago | 1092037 |
17. | Natixis Advisors, LLC. | 5 months ago | 891261 |
18. | Brandes Investment Partners & Co | 5 months ago | 864880 |
19. | Goldman Sachs Group Inc | 5 months ago | 787730 |
20. | SKBA Capital Management LLC | 5 months ago | 786466 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).